168 related articles for article (PubMed ID: 9269715)
1. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn.
Kumpel BM
Transfus Clin Biol; 1997 Jul; 4(4):351-6. PubMed ID: 9269715
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-D development programme.
Kumpel BM
Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
[TBL] [Abstract][Full Text] [Related]
4. Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.
Goodrick J; Kumpel B; Pamphilon D; Fraser I; Chapman G; Dawes B; Anstee D
Clin Exp Immunol; 1994 Oct; 98(1):17-20. PubMed ID: 7923878
[TBL] [Abstract][Full Text] [Related]
5. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
7. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
8. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
Kumpel BM
Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
[TBL] [Abstract][Full Text] [Related]
9. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.
Kumpel BM
Clin Exp Immunol; 2008 Oct; 154(1):1-5. PubMed ID: 18727626
[TBL] [Abstract][Full Text] [Related]
10. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
11. Murine monoclonal antibodies reactive with a human monoclonal anti-RhD antibody (BRAD-5).
Walker RY; Andrew S; Kumpel BM; Austin EB
Transfus Med; 2000 Sep; 10(3):225-31. PubMed ID: 10972918
[TBL] [Abstract][Full Text] [Related]
12. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).
Kumpel BM; De Haas M; Koene HR; Van De Winkel JG; Goodrick MJ
Clin Exp Immunol; 2003 Apr; 132(1):81-6. PubMed ID: 12653840
[TBL] [Abstract][Full Text] [Related]
13. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
Urbaniak SJ
Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
[No Abstract] [Full Text] [Related]
14. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
Daniels G; Finning K; Martin P; Summers J
Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.
Kumpel BM
Vox Sang; 2007 Aug; 93(2):99-111. PubMed ID: 17683353
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-D for immunoprophylaxis.
Scott ML
Vox Sang; 2001 Nov; 81(4):213-8. PubMed ID: 11903995
[TBL] [Abstract][Full Text] [Related]
17. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Stasi R
Curr Opin Mol Ther; 2010 Dec; 12(6):734-40. PubMed ID: 21154165
[TBL] [Abstract][Full Text] [Related]
18. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D.
Kumpel BM; Judson PA
Transfus Med; 1995 Jun; 5(2):105-12. PubMed ID: 7655572
[TBL] [Abstract][Full Text] [Related]
19. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
20. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
Harding K
Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
